Clinical Study on Oral Administration of "ruanjian Huayu Decoction" with External Application of "jiedu Xiaopi Powder" in Treating Early HBV-related Cirrhosis of Blood-Stasis Obstruction

LV Zhen,CHEN Xiao-rong

DOI: https://doi.org/10.16305/j.1007-1334.2012.10.010

2012-01-01

Abstract:Objective To observe and evaluate the therapeutic efficacy of Ruanjian Huayu Decoction with external application of Jiedu Xiaopi Powder in the treatment of early HBV-related cirrhosis of blood-stasis obstructing type.Methods A total of 80 early HBV-related cirrhosis patients diagnosed with blood-stasis obstruction were randomly divided into four groups: control group treated with entecavir only,internal application group treated with Ruanjian Huayu Decoction orally and entecavir,external application group treated with entecavir and point application of Jiedu Xiaopi Powder,and integrated group with internal application of Ruanjian Huayu Decoction,external application of Jiedu Xiaopi Powder and entecavir.After 6-month treatment,the changes of the clinical symptoms and syndromes,liver function,indexes of liver fibrosis were observed.Results The total effective rate was 90.0% in integrated group,which was significantly higher than those in control group,internal application group and the external application group(45.0%,55.0% and 60.0%)(P0.05,P0.01).All groups had significant improvement in ALT,AST and indexes of liver fibrosis after the treatment(P0.05,P0.01),and the difference of integrated group was superior to the other three groups(P0.05,P0.01).Conclusion Ruanjian Huayu Decoction with external application of Jiedu Xiaopi Powder have positive effects on protecting liver,lowering transaminase and fighting fibrosis for early HBV-related cirrhosis of blood-stasis obstruction.